ReviewFoxO1, the transcriptional chief of staff of energy metabolism

FoxO1, one of the four FoxO isoforms of Forkhead transcription factors, is highly expressed in insulin-responsive tissues, including pancreas, liver, skeletal muscle and adipose tissue, as well as in the skeleton. In all these tissues FoxO1 orchestrates the transcriptional cascades regulating glucose metabolism. Indeed, FoxO1 is a major target of insulin which inhibits its transcriptional activity via nuclear exclusion. In the pancreas, FoxO1 regulates β-cell formation and function by a balanced dual mode of action that suppresses β-cell proliferation but promotes survival. Hepatic glucose production is promoted and lipid metabolism is regulated by FoxO1 such that under insulin resistance they lead to hyperglycemia and dyslipidemia, two features of type 2 diabetes. In skeletal muscle FoxO1 maintains energy homeostasis during fasting and provides energy supply through breakdown of carbohydrates, a process that leads to atrophy and underlies glycemic control in insulin resistance. In a dual function, FoxO1 regulates energy and nutrient homeostasis through energy storage in white adipose tissue, but promotes energy expenditure in brown adipose tissue. In its most recently discovered novel role, FoxO1 acts as a transcriptional link between the skeleton and pancreas as well as other insulin target tissues to regulate energy homeostasis. Through its expression in osteoblasts it controls glucose metabolism, insulin sensitivity and energy expenditure. In a feedback mode of regulation, FoxO1 is also a target of insulin signaling in osteoblasts. Insulin suppresses activity of osteoblastic FoxO1 thus promoting beneficial effects of osteoblasts on glucose metabolism. The multiple actions of FoxO1 in all glucose-regulating organs, along with clinical studies suggesting that its glycemic properties are conserved in humans, establish this transcription factor as a master regulator of energy metabolism across species.This article is part of a Special Issue entitled: Interactions Between Bone, Adipose Tissue and Metabolism.

► FoxO1 orchestrates transcriptional cascades regulating glucose metabolism in insulin regulating and responsive tissues, pancreas, liver, skeletal muscle and adipose tissue. ► Through its expression in osteoblasts FoxO1 controls glucose metabolism, insulin sensitivity and energy expenditure. ► FoxO1 acts as a transcriptional link between the skeleton and pancreas and other insulin target tissues to regulate energy homeostasis. ► Clinical studies suggest that the glycemic properties of FoxO1 are conserved in humans. ► FoxO1 actions in peripheral glucose-regulating organs and the skeleton, establish it as a master regulator of energy metabolism across species.